Paper32077599
New epidemiology of hepatitis delta.
Vlachogiannakos J and 1 other. Liver Int, 2020. Cited by 42 papers, by iCite.
Cite this record
ConductScience Library. New epidemiology of hepatitis delta. Papers, record 32077599. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/32077599
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics10
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Carcinoma, Hepatocellular | Major topic |
| Coinfection | Major topic |
| Hepatitis B | Major topic |
| Hepatitis D | Major topic |
| Liver Neoplasms | Major topic |
| Europe | |
| Hepatitis B virus | |
| Hepatitis Delta Virus | |
| Humans | |
| Prevalence |
Source PubMed
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 42 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42357642 | Serological and Molecular Epidemiology of Hepatitis B, C, and D Viruses in Northwest Russia: A Population-Based Cross-Sectional Study. | Viruses | 2026 | https://conductscience.org/library/papers/42357642 | PubMed |
| 41754517 | Suboptimal Linkage to Care of Delta-Infected Patients in an Area with Increasing Migration-Driven Prevalence of Hepatitis D in Recent Years. | Viruses | 2026 | https://conductscience.org/library/papers/41754517 | PubMed |
| 41746099 | Towards HDV Elimination Through HBV Vaccination: Global Strategies, Challenges, and Policy Gaps. | Vaccines (Basel) | 2026 | https://conductscience.org/library/papers/41746099 | PubMed |
| 41408032 | Hepatitis A to E in People with HIV: A Virus-Specific Review of Prevention and Treatment. | Infect Dis Ther | 2026 | https://conductscience.org/library/papers/41408032 | PubMed |
| 41031102 | Regional Mortality From Chronic Liver Diseases in African Countries Attributable to Hepatitis B Virus and Hepatitis C Virus Infections From 1990 to 2021 and Projections to 2030. | Open Forum Infect Dis | 2025 | https://conductscience.org/library/papers/41031102 | PubMed |
| 40881490 | Hepatitis B virus and hepatitis D virus co-infection complicated by autoimmune hepatitis: Two case reports. | World J Clin Cases | 2025 | https://conductscience.org/library/papers/40881490 | PubMed |
| 40613912 | Proteins and peptides as antigen candidates for the immunodiagnosis of hepatitis D. | Amino Acids | 2025 | https://conductscience.org/library/papers/40613912 | PubMed |
| 40214253 | A universal point-of-care immunochromatographic test for the serodiagnosis of hepatitis D. | J Clin Microbiol | 2025 | https://conductscience.org/library/papers/40214253 | PubMed |
| 39980422 | Low coverage of hepatitis D virus testing in individuals with hepatitis B virus and HIV, the Netherlands, 2000 to 2022. | Euro Surveill | 2025 | https://conductscience.org/library/papers/39980422 | PubMed |
| 39599805 | Genetic Spatio-Temporal Analysis of Hepatitis D Virus Infection in Western Brazilian Amazon. | Viruses | 2024 | https://conductscience.org/library/papers/39599805 | PubMed |
| 38689751 | Prospective study of hepatitis B and D epidemiology and risk factors in Romania: A 10-year update. | World J Hepatol | 2024 | https://conductscience.org/library/papers/38689751 | PubMed |
| 38390020 | [Delta hepatitis in Africa: epidemiological and clinical particularities]. | Med Trop Sante Int | 2023 | https://conductscience.org/library/papers/38390020 | PubMed |
| 37632029 | Cellular Factors Involved in the Hepatitis D Virus Life Cycle. | Viruses | 2023 | https://conductscience.org/library/papers/37632029 | PubMed |
| 37512809 | Infectious Agents Induce Wnt/β-Catenin Pathway Deregulation in Primary Liver Cancers. | Microorganisms | 2023 | https://conductscience.org/library/papers/37512809 | PubMed |
| 37408247 | HDV RNA Levels and Progression of Hepatitis Delta Infection: A 14 Year Follow Up Experience in Italy. | Cells | 2023 | https://conductscience.org/library/papers/37408247 | PubMed |
| 36908749 | Strain-specific responsiveness of hepatitis D virus to interferon-alpha treatment. | JHEP Rep | 2023 | https://conductscience.org/library/papers/36908749 | PubMed |
| 36727249 | [Sero-epidemiological characteristics of the hepatitis D virus infection among hepatitis B virus infected-patients at a single center in Xinjiang region]. | Zhonghua Gan Zang Bing Za Zhi | 2022 | https://conductscience.org/library/papers/36727249 | PubMed |
| 36621853 | Diagnosis of HDV: From virology to non-invasive markers of fibrosis. | Liver Int | 2023 | https://conductscience.org/library/papers/36621853 | PubMed |
| 34717740 | Hepatitis D: challenges in the estimation of true prevalence and laboratory diagnosis. | Gut Pathog | 2021 | https://conductscience.org/library/papers/34717740 | PubMed |
| 34694876 | Can Interferon Therapy Change the Natural Course of Hepatitis Delta Infection?: a Clinical and Pathological Study. | Antimicrob Agents Chemother | 2022 | https://conductscience.org/library/papers/34694876 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/32077599
GET https://conductscience.org/api/papers/v1/32077599/cited_by?page=2